Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response after hepatitis B vaccine challenge dose in adults aged 50 years and older
2009-016721-33Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C
- Start
- Aug 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Sanofi Pasteur MSD S.N.C. Primary endpoints: Seroprotection rate before challenge dose and Seroprotection rate after challenge dose. Started Aug 2010; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2009-016721-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016721-33.